Dr Mou on the Significance of Efficacy Data for Tacabrutideg in CLL

Letter/Communication - Video

Open access

Eric Mou

Oncology live

07/21/2026

Files and links (1)

url

https://www.onclive.com/view/dr-mou-on-the-significance-of-efficacy-data-for-tacabrutideg-in-cllView

Published (Version of record) Open Access

Eric Mou, MD, discusses efficacy data for tacabrutideg in chronic lymphocytic leukemia and what these findings may mean for the field.

Internal Medicine

Title: Subtitle: Dr Mou on the Significance of Efficacy Data for Tacabrutideg in CLL
Creators: Eric Mou
Resource Type: Letter/Communication
Resource Sub-type: Video
Publication Details: Oncology live
ISSN: 2374-5347
eISSN: 2767-4924
Publisher: MultiMedia Healthcare Inc
Language: English
Date published: 07/21/2026
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9985219307202771

3 Record Views